Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 4 1Phase 2 1

Status

Unknown 2Completed 2

Sponsor Class

OTHER 3INDUSTRY 1

Study Type

Interventional 4Observational 2

Sponsor

Cancer Type

Other 4

Conditions

Obesity 298Mucositis 116Neoplasms 108Breast Neoplasms 87Overweight 80Sexual Dysfunction, Physiological 74Polycystic Ovary Syndrome 71Dyspnea 48Motor Activity 46Constipation 45Head and Neck Neoplasms 42Weight Loss 36Prostatic Neoplasms 32Pain 29Stomatitis 26Endometrial Neoplasms 23Opioid-Induced Constipation 21Multiple Endocrine Neoplasia Type 1 20Diabetes Mellitus 20Lung Neoplasms 18Colorectal Neoplasms 17Precursor Cell Lymphoblastic Leukemia-Lymphoma 16Sexual Dysfunctions, Psychological 15Depression 15Cardiovascular Diseases 15Anxiety Disorders 15Sedentary Behavior 13Insulin Resistance 13Infertility 13Cancer-related Fatigue 13

Interventions

licogliflozin 1Topiramate 1Ovidrel 1Dexamethasone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Interventional × Hyperandrogenism × Other × Clear all
NCT01421810 2023-10-27

CBS001

University of Virginia

Phase NA Unknown
80 enrolled
Other

Obesity, Polycystic Ovary Syndrome, Hyperandrogenism

NCT03902301 2022-04-26

ProjectPCOS

Poznan University of Life Sciences

Phase NA Completed
80 enrolled
Other

Insulin Resistance, Obesity, Polycystic Ovary Syndrome, Hyperandrogenism

NCT03152591 2021-01-05

PCOS

Novartis

Phase 2 Completed
29 enrolled 24 charts
Other

Insulin Resistance, Obesity, Polycystic Ovary Syndrome, Hyperandrogenism, Overweight

NCT04453306 2020-07-01

Treatment of Obesity With Topiramate in Patients With Polycystic Ovary Syndrome

Hospital de Clinicas de Porto Alegre

Phase 4 Unknown
80 enrolled
Other

Obesity, Polycystic Ovary Syndrome, Hyperandrogenism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡